Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152
暂无分享,去创建一个
J. Bourhis | G. Kroemer | V. Frascogna | P. Zhang | Y. Tao | M. Castedo | M Castedo | G Kroemer | Y. Tao | J Bourhis | E Deutsch | F. Girdler | Ping Zhang | Y Tao | P Zhang | F Girdler | V Frascogna | J. Bourhis | E. Deutsch | E. Deutsch | Guido Kroemer | Jean Bourhis
[1] L. Milas,et al. Combination of taxanes with radiation: preclinical studies. , 1999, Seminars in radiation oncology.
[2] David Bebbington,et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo , 2004, Nature Medicine.
[3] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[4] W. Earnshaw,et al. Chromosomal passengers and the (aurora) ABCs of mitosis. , 2001, Trends in cell biology.
[5] P. D. Andrews,et al. Aurora kinases: shining lights on the therapeutic horizon? , 2005, Oncogene.
[6] W. Earnshaw,et al. The cellular geography of Aurora kinases , 2003, Nature Reviews Molecular Cell Biology.
[7] K. Kinzler,et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.
[8] Erich A. Nigg,et al. Cell division: Mitotic kinases as regulators of cell division and its checkpoints , 2001, Nature Reviews Molecular Cell Biology.
[9] A. Venkitaraman,et al. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. , 2003, Cancer cell.
[10] M V Chernov,et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.
[11] Stephen S. Taylor,et al. Validating Aurora B as an anti-cancer drug target , 2006, Journal of Cell Science.
[12] Stephen S. Taylor,et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores , 2003, The Journal of cell biology.
[13] Brian Schryver,et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.
[14] J. Bourhis,et al. Caspase independence of radio-induced cell death , 2006, Oncogene.
[15] Guido Kroemer,et al. Cell death by mitotic catastrophe: a molecular definition , 2004, Oncogene.
[16] H. Saya,et al. Aurora-A and an Interacting Activator, the LIM Protein Ajuba, Are Required for Mitotic Commitment in Human Cells , 2003, Cell.
[17] K. Kinzler,et al. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage , 1999, Nature.
[18] Stephen S. Taylor,et al. Aurora-kinase inhibitors as anticancer agents , 2004, Nature Reviews Cancer.
[19] Kaori Sasai,et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53 , 2004, Nature Genetics.
[20] Jiri Bartek,et al. Cell-cycle checkpoints and cancer , 2004, Nature.
[21] B. Vogelstein,et al. The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells* , 2003, Journal of Biological Chemistry.
[22] Erich A Nigg,et al. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. , 2004, Current opinion in genetics & development.
[23] Rajesh Odedra,et al. AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis , 2007, Clinical Cancer Research.
[24] J. Ruderman,et al. Aurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts. , 2005, Molecular biology of the cell.
[25] Weikang Tao,et al. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. , 2005, Cancer cell.
[26] M. Loda,et al. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. , 2006, Cancer research.
[27] J. Peters,et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint , 2003, The Journal of cell biology.
[28] T. Pawlik,et al. Role of cell cycle in mediating sensitivity to radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[29] R. Klinke,et al. A Chemical Inhibitor of p 53 That Protects Mice from the Side Effects of Cancer Therapy , 1999 .
[30] C. Prigent,et al. Aurora kinases, aneuploidy and cancer, a coincidence or a real link? , 2005, Trends in cell biology.
[31] Jiri Bartek,et al. Targeting the checkpoint kinases: chemosensitization versus chemoprotection , 2004, Nature Reviews Cancer.